- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Amine oxidase.
Displaying page 1 of 1.
EudraCT Number: 2008-002089-74 | Sponsor Protocol Number: Matyus-2008/1 | Start Date*: 2008-08-15 | |||||||||||||||||||||
Sponsor Name:Semmelweis University | |||||||||||||||||||||||
Full Title: The investigation of the effect of dihydralazine (Depressan) on macular edema of type 2 diabetes patients and of inhibition of semicarbazide-sensitive amine oxidase (SSAO). | |||||||||||||||||||||||
Medical condition: Macular edema in patients with type 2 diabetes. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: HU (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002393-37 | Sponsor Protocol Number: RG_13-027 | Start Date*: 2015-01-06 | |||||||||||
Sponsor Name:University of Birmingham | |||||||||||||
Full Title: A single arm, two-stage, multi-centre, phase II clinical trial investigating the safety and activity of the use of BTT1023, a human monoclonal antibody targeting vascular adhesion protein (VAP-1), ... | |||||||||||||
Medical condition: Primary Sclerosing Cholangitis (PSC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001970-33 | Sponsor Protocol Number: 167700-002CL | Start Date*: 2013-07-19 | |||||||||||
Sponsor Name:Proximagen Limited | |||||||||||||
Full Title: A Double-Blind, Randomised, Exploratory Study to Investigate the Safety, Efficacy and Pharmacokinetics of PRX167700 in Subjects with Knee Osteoarthritis. | |||||||||||||
Medical condition: Osteoarthritis of the knee | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000499-83 | Sponsor Protocol Number: 1386.4 | Start Date*: 2017-05-04 | |||||||||||
Sponsor Name:Boehringer Ingelheim bv | |||||||||||||
Full Title: A multi-centre, double-blind, parallel-group, randomised, placebo controlled phase II a study to investigate safety, tolerability, pharmacodynamics, and harmacokinetics of different doses of orall... | |||||||||||||
Medical condition: Non-alcoholic steatohepatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) BE (Completed) DE (Completed) IE (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
